Mid Europa’s Walmark acquires Pneumolan
CEE-based consumer healthcare business Walmark, backed by Mid Europa, has acquired a range of products that trade under the Pneumolan brand from Novascon Pharmaceuticals.
Mid Europa acquired a 50% stake in Walmark in July 2012 from the company's founders. The GP has since supported the company's buy-and-build strategy, which has seen Walmark previously acquire sinus and upper-respiratory product manufacturer Sinulan, also from Novascon, in April 2014.
Walmark was founded in 1990 and is headquartered in Třinec, Czech Republic, with an additional office in Prague. The company develops dietary supplements and exports to Slovakia, Romania, Bulgaria, Hungary, Poland and the Baltic states.
Company
Poland-based Pneumolan specialises in children's natural products for respiratory ailments. Its parent company, Novascon, was founded in 2007 and is headquartered in Warsaw.
People
Jorge Manuel is the CEO of Walmark. Michelle Capiod is a partner at Mid Europa.
Advisers
Company – Vienna Capital Partners (Corporate finance); Pharmabroker (Corporate finance); Baker & McKenzie (Legal); EY (Financial due diligence).
More on CEE
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Trind VC plans up to five early-stage investments in next six months
VC has deployed around 10% of its second, EUR 55m fund and plans to invest in up to 40 startups
Letter from the editor: Unquote is moving to Mergermarket
Unquote Editor Harriet Matthews outlines Unquote.com's upcoming move to the Mergermarket platform and the new capabilities and intelligence that this brings to Unquote readers
Actera Group explores strategic options for Celebi Ground Handling
Several investors placed bids for the company in 2022 but mismatch in pricing didn't lead to a deal
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater